Innovassynth Technologies Reports Turnaround: Posts Rs 1.50 Crore Q2 Profit

Profit after tax (PAT) rose to Rs 1.50 crore from a Rs 14.28 crore loss last year. Revenue jumped to Rs 47.55 crore from Rs 17.28 crore in the same period.

Reader Takeaway: Strong operational turnaround in specialty chemicals business provides momentum, while leadership stability is secured via MD reappointment.

What just happened

Innovassynth Technologies (India) Ltd has released its financial results for the quarter and half-year ended September 30, 2026. The company successfully reversed its year-ago losses, achieving a PAT of Rs 8.23 crore for the first half of the fiscal year. These figures reflect a restated basis following the December 2025 merger with ITIL. Additionally, the Board of Directors has moved to extend the tenure of Dr. Hardik Joshipura as Managing Director and CEO for three years, starting February 12, 2027.

Why this matters

The return to profitability serves as a critical indicator that the firm's strategic focus on specialty chemicals and pharmaceutical intermediates is yielding results post-merger. For investors, the combination of a sharp revenue increase and the stabilization of the bottom line suggests improved operational efficiency. The clear leadership roadmap for the next three years removes uncertainty regarding management continuity.

Context metrics

Revenue for H1 FY27 reached Rs 103.53 crore, a significant leap from the restated H1 FY26 revenue of Rs 29.55 crore. Profit before tax for H1 FY27 stands at Rs 12.80 crore, compared to a loss of Rs 33.29 crore in the same period of the previous year.

What to track next

Shareholders will now look to the upcoming general meeting to ratify the re-appointment of Dr. Joshipura. Continued focus will remain on whether the company can maintain these margins in the competitive specialty chemicals space through the remainder of FY27.